Genome profiling of ovarian adenocarcinomas using pangenomic BACs microarray comparative genomic hybridization
Open Access
- 1 January 2008
- journal article
- Published by Springer Nature in Molecular Cytogenetics
- Vol. 1 (1) , 10
Abstract
Routine cytogenetic investigations for ovarian cancers are limited by culture failure and poor growth of cancer cells compared to normal cells. Fluorescence in situ Hybridization (FISH) application or classical comparative genome hybridization techniques are also have their own limitations in detecting genome imbalance especially for small changes that are not known ahead of time and for which FISH probes could not be thus designed.Keywords
This publication has 57 references indexed in Scilit:
- High definition cytogenetics and oligonucleotide aCGH analyses of cisplatin‐resistant ovarian cancer cellsGenes, Chromosomes and Cancer, 2008
- Genomic tests for ovarian cancer detection and management.2006
- Serum CA125 level modifications in women undergoing repeated IVF cycles.2006
- Higher frequency of chromosomal aberrations in ovarian endometriosis compared to extragonadal endometriosis: a possible link to endometrioid adenocarcinomaLaboratory Investigation, 2006
- Rapid detection of genomic imbalances using micro-arrays consisting of pooled BACs covering all human chromosome armsNucleic Acids Research, 2005
- Molecular cytogenetics of ovarian granulosa cell tumors by comparative genomic hybridizationGynecologic Oncology, 2005
- Comparing the genetic changes detected in the primary and secondary tumor sites of ovarian cancer using comparative genomic hybridizationInternational Journal of Gynecological Cancer, 2005
- Cytogenetic alterations in ovarian clear cell carcinoma detected by comparative genomic hybridisationBritish Journal of Cancer, 2003
- Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays.2002
- Patterns of genomic imbalances in human solid tumors (Review).International Journal of Oncology, 2000